Raymond James Financial Services Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $41.7M | Buy |
622,342
+7,211
| +1% | +$592K | 0.06% | 318 |
|
|
2024
Q2 | $69.7M | Buy |
615,131
+34,905
| +6% | +$4.41M | 0.1% | 197 |
|
|
2024
Q1 | $80.5M | Buy |
580,226
+425,880
| +276% | +$53.5M | 0.12% | 169 |
|
|
2023
Q4 | $19.2M | Buy |
154,346
+11
| +0% | +$1.12K | 0.03% | 506 |
|
|
2023
Q3 | $14.4M | Buy |
154,335
+16,504
| +12% | +$1.86M | 0.03% | 563 |
|
|
2023
Q2 | $17.7M | Buy |
137,831
+36,725
| +36% | +$4.44M | 0.03% | 505 |
|
|
2023
Q1 | $11.7M | Buy |
101,106
+3,211
| +3% | +$359K | 0.02% | 635 |
|
|
2022
Q4 | $11.1M | Sell |
97,895
-976
| -1% | -$107K | 0.02% | 610 |
|
|
2022
Q3 | $7.96M | Sell |
98,871
-1,884
| -2% | -$160K | 0.02% | 714 |
|
|
2022
Q2 | $7.51M | Sell |
100,755
-7,297
| -7% | -$666K | 0.02% | 742 |
|
|
2022
Q1 | $13.8M | Buy |
108,052
+11,516
| +12% | +$1.26M | 0.03% | 565 |
|
|
2021
Q4 | $13M | Buy |
96,536
+288
| +0.3% | +$41.4K | 0.02% | 581 |
|
|
2021
Q3 | $13.2M | Buy |
96,248
+1,736
| +2% | +$219K | 0.03% | 568 |
|
|
2021
Q2 | $10.1M | Sell |
94,512
-12,692
| -12% | -$1.22M | 0.02% | 661 |
|
|
2021
Q1 | $9.63M | Buy |
107,204
+9,460
| +10% | +$888K | 0.02% | 642 |
|
|
2020
Q4 | $9.03M | Buy |
97,744
+26,528
| +37% | +$2.37M | 0.02% | 595 |
|
|
2020
Q3 | $7.34M | Sell |
71,216
-10,628
| -13% | -$1.11M | 0.02% | 606 |
|
|
2020
Q2 | $8.29M | Buy |
81,844
+30,368
| +59% | +$2.72M | 0.03% | 520 |
|
|
2020
Q1 | $3.46M | Buy |
51,476
+3,664
| +8% | +$228K | 0.02% | 646 |
|
|
2019
Q4 | $2.62M | Buy |
47,812
+1,200
| +3% | +$56.9K | 0.01% | 1043 |
|
|
2019
Q3 | $1.74M | Buy |
46,612
+3,292
| +8% | +$128K | 0.01% | 1182 |
|
|
2019
Q2 | $1.62M | Buy |
43,320
+896
| +2% | +$28.2K | 0.01% | 1220 |
|
|
2019
Q1 | $1.26M | Buy |
42,424
+9,252
| +28% | +$325K | 0.01% | 1324 |
|
|
2018
Q4 | $994K | Buy |
33,172
+524
| +2% | +$16.6K | 0.01% | 1271 |
|
|
2018
Q3 | $1.17M | Buy |
32,648
+5,368
| +20% | +$166K | 0.01% | 1374 |
|
|
2018
Q2 | $648K | Buy |
27,280
+1,284
| +5% | +$27.2K | ﹤0.01% | 1694 |
|
|
2018
Q1 | $482K | Sell |
25,996
-296
| -1% | -$4.38K | ﹤0.01% | 1736 |
|
|
2017
Q4 | $377K | Sell |
26,292
-34,272
| -57% | -$445K | ﹤0.01% | 1876 |
|
|
2017
Q3 | $741K | Sell |
60,564
-9,376
| -13% | -$166K | ﹤0.01% | 1490 |
|
|
2017
Q2 | $1.28M | Sell |
69,940
-2,368
| -3% | -$43.7K | 0.01% | 1111 |
|
|
2017
Q1 | $1.53M | Buy |
72,308
+560
| +0.8% | +$10.9K | 0.01% | 953 |
|
|
2016
Q4 | $1.07M | Buy |
71,748
+5,200
| +8% | +$92.1K | 0.01% | 1076 |
|
|
2016
Q3 | $1.46M | Sell |
66,548
-2,792
| -4% | -$62.1K | 0.01% | 893 |
|
|
2016
Q2 | $1.38M | Buy |
69,340
+112
| +0.2% | +$1.91K | 0.01% | 893 |
|
|
2016
Q1 | $1.18M | Sell |
69,228
-8,572
| -11% | -$143K | 0.01% | 833 |
|
|
2015
Q4 | $1.59M | Buy |
77,800
+6,344
| +9% | +$132K | 0.02% | 730 |
|
|
2015
Q3 | $1.53M | Buy |
+71,456
| New | +$1.59M | 0.03% | 621 |
|
|
2013
Q3 | – | Sell |
-137,228
| Closed | -$770K | – | 598 |
|
|
2013
Q2 | $770K | Buy |
+137,228
| New | +$657K | 0.02% | 705 |
|
Other funds holding DXCM
N
Raymond James Financial Services Advisors's DXCM Position: Q3 2024 in Review
Raymond James Financial Services Advisors increased its DexCom (DXCM) stake by 1.2% in Q3 2024, buying an estimated $592K and bringing the position to 622,342 shares worth $41.7M. The position accounts for 0.06% of the portfolio, ranked #318.
Raymond James Financial Services Advisors first reported a position in DXCM in Q2 2013 and has held it in 38 quarters since. The position peaked at $80.5M in Q1 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.
- Raymond James Financial Services Advisors held 622,342 shares of DexCom worth $41.7M as of Q3 2024.
- Raymond James Financial Services Advisors bought 7,211 DexCom shares in Q3 2024, an estimated $592K.
- DexCom made up 0.06% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #318 holding.
- Raymond James Financial Services Advisors first reported a position in DexCom in Q2 2013 and has held it in 38 quarters since.
- Raymond James Financial Services Advisors's DexCom position peaked at $80.5M in Q1 2024.
- 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.